Assay Search

How can we help?

US - Local: 301.738.1000

Toll Free: 800.756.5658

Click here to contact us

Click on the assay title that you’re interested in for further detailed information.

Assay No. Assay Title Service Phase Therapeutic Type
003000.BSV
GMP: 003800.BSV
28-day In Vitro Virus Assay GLP, 3 Cell Lines  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
003003.BSV
28-day In Vitro Virus Assay GLP, 6 Cell Lines  Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
003000NG.BSV
GMP: 003800.BSV
28-day In Vitro Virus Assay Non-GLP, 3 Cell Lines  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
011604.BSV
293 Cells / Feline S+L- Assay With RD-114 FLV Control for RCR Detection (up to 1 x 10^7)  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Gene Therapy 
011600.BSV
293 Cells / Feline S+L- Assays for RCR Detection - Co-Cultivation (up to 1 x 10^7)  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Gene Therapy 
009600.BSV
293 Cells Amplification for RCR Detection (1-22 ml)  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Gene Therapy 
009601.BSV
293 Cells Amplification for RCR Detection (56-110 ml)  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Gene Therapy 
009601.BSV
293 Cells Amplification for RCR Detection (56-110 ml)  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Gene Therapy 
016005.BSV
293 HEK Host Cell Protein Detection by Immunoassay  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization     
011005.BSV
A549 Cells / RT and Mink S+L- Assays for Retrovirus Detection  Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Monoclonal Antibody, Recombinant Protein 
105044.BSV
Adeno-Associated Virus (AAV) Serotypes 1, 2, 3, 3B, 4 and 6 by PCR  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 3  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
105044FR.BSV
Adeno-Associated Virus (AAV) Serotypes 1, 2, 3, 3B, 4 and 6 by PCR  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization     
105240.BSV
Adenovirus E1A Sequence Detection by qPCR  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 1, Phase 2, Phase 3  Gene Therapy 
102017.BSV
Agar / Non Agar-Cultivable Mycoplasma from a Filtered Test Article in Accordance with 1993 FDA PTC  Biologics Safety Testing > Bulk Lot Release Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Gene Therapy, Monoclonal Antibody, Recombinant Protein 
402901.BSV
Amino Acid Analysis (Non-GLP)  Biologics Safety Testing > Analytical Testing, Biologics Safety Testing > Final Product Release Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Monoclonal Antibody, Recombinant Protein 
402801GMP.BSV
Amino Acid Analysis, GMP  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Final Product Release Testing  Research, Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product   
009001.BSV
GMP: 009001GMP.BSV
Ampho- and Xenotropic Murine Retrovirus by Extended Mink S+L-Focus Assay  Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 3  Monoclonal Antibody, Recombinant Protein 
408803GMP.BSV
Appearance Test, GMP  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Final Product Release Testing  Research, Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product   
510010.BSV
Bioburden Assay for Non-Sterile Materials, GLP  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Final Product Release Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
032900.BSV
GMP: 033900GMP.BSV
Bovine 9CFR In Vitro Assay for 7 Viruses  Biologics Safety Testing > Cell and Virus Characterization, Biologics Safety Testing > Raw Material Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
032900NRT.BSV
GMP: 033900GMP.BSV
Bovine 9CFR In Vitro Assay for 7 Viruses (Non-GxP)  Biologics Safety Testing > Cell and Virus Characterization, Biologics Safety Testing > Raw Material Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
032901.BSV
GMP: 032901GMP.BSV
Bovine 9CFR In Vitro Assay for 9 Viruses  Biologics Safety Testing > Cell and Virus Characterization, Biologics Safety Testing > Raw Material Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
032901NRT.BSV
GMP: 032901GMP.BSV
Bovine 9CFR In Vitro Assay for 9 Viruses (Non-GxP)  Biologics Safety Testing > Cell and Virus Characterization, Biologics Safety Testing > Raw Material Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
032004.BSV
Bovine In Vitro Assay for 5 Viruses  Biologics Safety Testing > Cell and Virus Characterization, Biologics Safety Testing > Raw Material Testing  Preclinical, Phase 1, Phase 2, Phase 3, Licensed Product  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines 
105054.BSV
Bovine Papilloma Virus Type 1 and 2 Detection by PCR  Biologics Safety Testing > Bulk Lot Release Testing, Biologics Safety Testing > Cell and Virus Characterization  Preclinical, Phase 3  Cell Therapy, Gene Therapy, Monoclonal Antibody, Recombinant Protein, Vaccines